Searched over 200M research papers
10 papers analyzed
These studies suggest dyspnea is a subjective experience of breathing discomfort influenced by various physiological, psychological, and neural factors, requiring rapid evaluation and targeted interventions for effective management.
20 papers analyzed
Dyspnea, commonly known as breathlessness or shortness of breath, is a subjective experience of breathing discomfort that varies in intensity and quality. It is a prevalent symptom, affecting up to 25% of patients in ambulatory settings and is reported in up to 4 million emergency room visits annually in the United States alone . Dyspnea can be acute or chronic, with chronic dyspnea defined as lasting more than four weeks.
Dyspnea can arise from a multitude of underlying conditions, making it a diagnostic challenge. The primary causes include cardiac diseases such as congestive heart failure and acute coronary syndrome, and pulmonary diseases like pneumonia and chronic obstructive pulmonary disease (COPD) . Other contributing factors include anemia, mental disorders, and even certain medications, such as P2Y12 inhibitors used in cardiovascular treatments .
The perception of dyspnea is not solely dependent on physical conditions but is also significantly influenced by psychological and biopsychological factors. Anxiety, depression, hormone status, gender, body weight, and general fitness level can exacerbate the sensation of dyspnea, increasing its severity and reducing the quality of life . Neuroimaging studies have shown that dyspnea involves complex neural mechanisms, including the cortico-limbic areas of the brain associated with interoception and nociception .
Dyspnea results from a mismatch between the respiratory motor output intended by the brain and the actual ventilatory output achieved. This mismatch is detected by various brain regions, although the exact mechanisms and pathways remain poorly understood. The sensation of dyspnea is also influenced by afferent signals from respiratory muscles and blood gas levels related to hypercapnia and hypoxia .
In COPD, dyspnea is a critical symptom associated with limited physical activity, increased anxiety and depression, decreased health-related quality of life, and reduced survival. The mechanisms contributing to dyspnea in COPD are varied and complex, necessitating the use of subjective clinical and psychophysical scales for assessment.
Dyspnea is also reported in Parkinson's disease (PD), where it is linked with anxiety and ventilation control impairment. The Multidimensional Dyspnea Profile (MDP) questionnaire helps distinguish the perceptive and emotional dimensions of dyspnea in PD patients.
Despite advances in understanding the mechanisms of dyspnea, effective treatment remains a challenge. Common approaches include pulmonary rehabilitation, breathing strategies, and supplemental oxygen, although these methods are not always fully effective. There is a critical need for evidence-based treatments and interdisciplinary translational research to connect dyspnea mechanisms with clinical treatment.
Dyspnea is a multifaceted symptom with diverse causes and complex underlying mechanisms. Its management requires a comprehensive understanding of both physiological and psychological factors. Continued research and interdisciplinary efforts are essential to develop more effective treatments and improve the quality of life for patients experiencing dyspnea.
Most relevant research papers on this topic